Capital Markets & Financings 

• Represented Profound Medical Corp. on multiple cross-border equity financings, including a US$40.25 million underwritten public offering, a US$20 million public offering, a US$36 million registered direct offering, and related private placements.
• Advised Satellos Bioscience Inc. on its US$57 million cross-border public offering and concurrent listing on the Nasdaq Global Market, a US$40 million public offering, on its graduation to the Toronto Stock Exchange, and its C$55 million public offering of common shares and pre-funded warrants.
• Represented Perimeter Medical Imaging AI, Inc. in multiple financings, including a C$3.6 million placement and a prospectus offering, as well as non-brokered private capital raises.
• Acted for AbraSilver Resource Corp. across a series of financings, including a C$43 million bought deal LIFE offering, a C$28.5 million private placement, a C$30 million public offering, a non-brokered US$1 million placement tied to an option and joint venture, and C$20 million in strategic investments by Kinross Gold Corporation and an affiliate of Central Puerto SA.
• Counsel to Silver Mountain Resources Inc. on its initial public offering and subsequent capital markets transactions, including an oversubscribed C$25 million bought deal prospectus offering and additional prospectus offerings and non-brokered private placements. 
  Represented Rivalry Corp. in growth and balance-sheet transactions, including multiple private placements, a debt restructuring, and a C$14 million strategic investment.
• Advised VIQ Solutions Inc. in connection with its C$18 million registered direct offering and C$4.8 million private placement.
• Acted for Fire & Flower in connection with its brokered offering of secured convertible debentures with a C$19.8 million principal amount and C$8.2 million of subscription receipts.
• Acted for underwriters and agents on a range of financings, including ATB Securities in connection with an at-the-market distribution program for Glass House Brands; Canaccord Genuity on a C$23 million bought deal public offering; Stifel Canada on Nervgen’s C$23 million bought deal prospectus offering; Oppenheimer & Co. on Electrovaya’s oversubscribed US$28.1 million public offering; Echelon Wealth Partners in connection with Skylight Health Group's C$5.75 million and C$13.8 million bought deal prospectus offerings; and Raymond James on Blackrock Silver’s C$13.8 million bought deal prospectus offering. 

M&A, Special Committees, Strategic Transactions & Special Situations

• Served as special committee counsel on significant transactions, including the going-private transaction for LifeSpeak Inc.; the acquisition of Magnet Forensics Inc. by Thoma Bravo; the acquisition of UGE International Ltd. by NOVA Infrastructure Fund; and the acquisition of FAX Capital Corp. by Fax Investments Inc.
• Counsel to Northampton Capital Partners LLC on its court‑approved plan of arrangement with Altius Renewable Royalties Corp.
• Acted for Sierra Metals Inc. in responding to a hostile bid.
• Advised Safety Shot, Inc. on its acquisition of Yerbaé Brands Corp.
• Advised Entourage Health Corp. on its going-private transaction, an increase to its senior secured credit facility, a restructuring of senior secured debt, and related debt financing transactions.
• Counsel to TenX Protocols Inc. on its reverse takeover of Iocaste Ventures Inc. and related C$29.9 million brokered and non-brokered offerings of subscription receipts (consisting of approximately C$6.36 million in cash and approximately C$23.56 million in crypto assets).
• Counsel to U92 Energy Corp on its reverse takeover of Sprock-it Acquisitions Ltd. and related C$3.83 million brokered offering of subscription receipts.
• Advised Clever Leaves Holdings Inc. in connection with its listing on the Nasdaq Capital Market following a business combination with Schultze Special Purpose Acquisition Corp.
• Advised Avicanna Inc. in connection with its non-offering prospectus and listing on the Toronto Stock Exchange.
• Served as Canadian counsel to Akanda Corp. in connection with its $16 million initial public offering of common shares and listing on the Nasdaq Capital Market.